Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
Mediwound宣佈美國食品和藥物管理局批准Nexobrid®用於治療嚴重燒傷的兒童患者
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
Mediwound宣佈美國食品和藥物管理局批准Nexobrid®用於治療嚴重燒傷的兒童患者
譯文內容由第三人軟體翻譯。